NCT06716814 2026-04-20
LIBERTY
Swedish Orphan Biovitrum
Phase 3 Recruiting
Clinical Trials
12 trialsNCT06617897 2026-03-11
Phase 3 Study of Fibrinogen Concentrate (CSL511) in Subjects With Pseudomyxoma Peritonei Undergoing Cytoreductive Surgery
CSL Behring
Phase 3 Recruiting
NCT01280825 2026-03-04
The 1200 Patients Project: Studying the Implementation of Clinical Pharmacogenomic Testing
University of Chicago
Recruiting
NCT06963216 2026-02-27
A Study Investigating Coagadex in the Treatment AFXD Associated With AL Amyloidosis
Kedrion S.p.A.
Phase 3 Recruiting
NCT04517461 2024-02-29
MVL-COAG
Region Skane
Completed
NCT05939960 2023-07-11
GCTHCM
Tianjin Medical University General Hospital
Unknown
NCT00127543 2021-01-05
Kid Cards: Teaching Kids About Medicines
Children's Mercy Hospital Kansas City
Phase NA Withdrawn
NCT01998828 2020-04-20
Safety and Efficacy of Momelotinib in Subjects With Polycythemia Vera or Essential Thrombocythemia
Sierra Oncology LLC - a GSK company
Phase 2 Terminated
NCT01787552 2020-04-15
A Phase Ib/II Dose-finding Study to Assess the Safety and Efficacy of LDE225 + INC424 in Patients With MF
Novartis
Phase 1/2 Completed
NCT00079716 2014-12-18
Study of SGN-40 in Patients With Refractory or Recurrent Multiple Myeloma
Seagen Inc.
Phase 1 Completed
NCT00525447 2014-10-09
Study of SGN-40, Lenalidomide, and Dexamethasone in Patients With Multiple Myeloma
Seagen Inc.
Phase 1 Completed
NCT00210197 2013-07-26
EHC
Institut Bergonié
Completed